Webcasts



Diagnosis and management of acute coronary syndromes

Webcast EPCCS 2014, Brussels
Dr. Frans Rutten (Utrecht, The Netherlands) discusses when to suspect ACS and what treatment de GP can initiate before transfer to the hospital, and how secondary prevention should be managed.

Degenerative valve disease:

Webcast EPCCS 2014, Brussels
Dr. Xavier Borras (Barcelona, Spain) highlights the important role of primary care physicians in adequate selection of patients with degenerative valve disease, to ensure useful valve replacement  procedures.

Prevention of Stroke: an important role for the GP

Webcast EPCCS 2014, Brussels
Dr. Monika Hollander, Utrecht, The Netherlands, emphasis the role of lifestyle modification, medication and recommendations for individualisation of therapy in the prevention and management of stroke and TIA in primary care

Tailored treatment of venous thromboembolism

Webcast London
Prof.dr. David Fitzmaurice discusses two existing controversies in the current guidelines concerning venous thromboembolism: treatment choice and treatment duration, including when it is better to stop treatment.

What to consider in the case of stable angina

Webcast London
Frans Rutten outlined which aspects are vital to consider in case of stable angina, as well as the distinction between stable angina and acute coronary syndrome.

Simplified approach to select patients for CRT

Webcast London
Prof. Dickstein attempts to simplify the relatively complicated guidelines on selection of patients who need to be referred for CRT, by focussing on left bundle branch block.

Cardiovascular disease prevention: a life-long task

Webcast London
Prof. Martin Scherer (Hamburg, Germany) discusses the importance of preventive measures, to reduce cardiovascular disease burden and disability, and what to focus on in cardiovascular disease preventive efforts.

Diagnosing pulmonary embolism

Webcast London
Dr. Geert-Jan Geersing speaks about how pulmonary embolism (PE) can be diagnosed. The role of the GP goes beyond referring patients with suspected PE; it is particularly important to rule out patients who do not need to be referred.

Renal denervation for truly resistant hypertension

Webcast London
Prof.dr. Roland Schmieder (Erlangen, Germany) discusses which patients with truly resistant hypertension are eligible for renal denervation.

ENGAGE: Factor Xa inhibitor edoxaban with promising results

Webcast AHA 2013
Dr. Bob Giugliano, senior investigator at TIMI group and associate professor at Harvard, discusses the results and implications of the recently at the AHA 2013 presented ENGAGE trial which evaluated edoxaban, the most recent Factor Xa inhibitor.

Cholesterol guideline breaking news in USA

Webcast AHA 2013
The new AHA/ACC cardiovascular prevention guideline was subject of controversy in the USA: the risk calculator and the use of statins were heavily discussed at the meeting of the American Heart Association in Dallas. Dr. Clyde Yancy, former AHA president, summarises what happened and why.

What's new in hypertension guidelines?

Webcast EPCCS, September 5-6, 2013
Richard McManus (Oxford, UK) discusses the target blood pressure of 140 over 90 for most patients in recent international guidelines and the problem of blood pressure measurement in obesity. 

How to encourage your patient to stop smoking?

Webcast EPCCS, September 5-6, 2013
Stopping smoking is a great preventive treatment. It can be done best by moving the conversation with your patient to help and offering support, according to Paul Aveyard (Oxford, UK).

When does diagnosing heart arrhythmias matter?

Webcast EPCCS 2013, London
John Camm MD (London) discusses the risk of tromboembolism with atrial fibrillation, current scoring systems, guidelines and antitrombotic medication and anticoagulants.

Diagnostic tests in daily practice

Webcast London, 5-6 September 2013
There is an increasing number of  novel diagnostic tests for cardiovascular disease. How does a GP determine if such a test may be useful in daily practice? Prof. Arno Hoes (Utrecht, The Netherlands) discusses the evidence and practical issues.

6th EPCCS Scientific Meeting

Webcast London, 5-6 September 2013
Chairman prof. Richard Hobbs (Oxford, UK) looks back at the 6th EPCCS Annual Scientific Meeting in London. It has been an interactive meeting with many dilemmas and take home messages that a GP can use in daily clinical practice.

Future developments in treating hyperglycemia in type 2 diabetes

Webcast London, 5-6 September 2013
Dr. Neil Munro (Esher, UK) discusses new agents for the treatment of hyperglycemia in type 2 diabetes. Interesting developments, but yet to come.

New tools to reduce stroke in AF

Webcast London, 5-6 September 2013
Prof. John Eikelboom (Ontario, Canada) has no doubt: the new oral anticoagulants are here to stay. They are valuable additional tools to reduce the burden of stroke in atrium fibrillation (AF).

Diabetes and cardiovascular disease

Webcast 2012
Prof. Johan Wens ,  Belgium discuss the relation of Diabetes and Cardiovascular Disease and its relevance for primary care

Cardiovascular dilemmas in case studies

Webcast EPCCS 2012
Prof. Martin Scherer , Germany, with case studies about the dilemmas GPs might face in managing CVD in daily practice

New 2012 ESC Atrial Fibrillation guidelines: Need to advance

Webcast EPCCS 2012
Prof. Christos Lionis , Greece, about the relevance of the new  ESC Atrial Fibrillation guidelines for European primary care

What is the best method for diagnosing hypertension?

Webcast EPCCS 2012
Prof. Richard McManus , Oxford, UK about new methods for diagnosing hypertension in primary care

How to recognize TIA and what to do?

Webcast EPCCS 2012
Dr. Dan Lasserson , Oxford, UK about Transient Ischaemic Attacks (TIA) and what to do in primary care

Early diagnosis of heart failure: the value of diagnostic algorithms

Webcast EPCCS 2012
Prof. Arno Hoes, Utrecht,Netherlands, about the rationale for early diagnosis of heart failure in general practice

New options for stroke prevention in patients with AF

Webcast EPCCS 2012
Prof. Richard Hobbs , Oxford, UK, about  the potential role of novel anticoagulants in primary care

Update on Familial Hypercholesterolaemia

Webcast EPCCS 2012
Dr. Carlos Brotons , Barcelona, Spain, about the importance of diagnoses and management of patients with FH in general practice

High-risk patients with aortic stenosis: New options

Webcast
View Prof. John Chambers , London, United Kingdom, discussing valve disease as common disorder of which a large proportion of patients is not being diagnosed due to a lack of awareness in the community, as presented in a satellite symposium during the 5th Annual meeting of the EPCCS in Athens. Get up to date in only 3 minutes This session was sponsored through an educational grant provided by Edwards Lifesciences

Optimising Lipid Management in Stable Disease

Webcast
Optimising Lipid Management in Stable Disease Prof. Furio Colivicchi  (San Filippo Neri Hospital Rome, Italy)

New oral anticoagulants for venous thromboembolism

Webcast
New oral anticoagulants for venous thromboembolism Prof. Henri Bounameaux (Geneva, Switzerland)

The future of lipid management in stroke

Webcast
Prof. Pierre Amarenco (Paris, France) describes how stroke can be prevented with statins and which patients already having stroke should receive statins.

Problems with oral anticoagulants in clinical practice

Webcast
Dr. Fokko de Haan (Germany) discusses daily problems with the new oral anticoagulants.

Do biomarkers have a role in CVD prediction or follow-up?

Webcast
Prof. Arno Hoes (Utrecht, The Netherlands) discusses new biomarkers for predicting of future cardiovascular disease being developed in recent years .

What do GPs need to know about this new CVD epidemic

Webcast
Prof. Richard McManus (Birmingham, United Kingdom) explains what CKD is and how it should be treated, from the GP viewpoint.

My top ten studies in primary care

Webcast
Prof. Martin Scherer summarizes his favourite publications of primary care studies.

HF Management & Monitoring

Webcast
Prof. Martin R. Cowie Good HF management does require a team approach. A nurse-led multidisciplinary programme could be of added value to patients.

Update on HF Management

Webcast
Prof. Martin R. Cowie , Imperial College, London, United Kingdom There have been two very important randomized trials in the field of heart failure in the past 12 months, which should have an impact in everybody’s practice.

Controversies in HF diagnosis

Webcast
Dr. Frans Rutten clarifies which symptoms are suspicious for heart failure and which tests can be used .

What's new in diabetes?

Webcast
Dr. Neil Munro discusses several new developments in diabetes relevant for primary care.

Update on hypertension

Webcast
Prof. Richard McManus discusses the shift in diagnosis of hypertension from clinic measurement to ambulatory and home measurement.

Early recognition and treatment of TIA

Webcast
Prof. Pierre Amarenco discusses the importance of early recognition and treatment of TIAs to ensure a better prognosis.

Hobbs' overview of EPCCS 2011

Webcast
Prof. Richard Hobbs gives an overview of highlights from EPCCS 2011, with a summary of sessions that were held, e.g. concerning lifetime cardiovascular risk, hypertension, diabetes, and chronic kidney disease.

Lifetime CV risk

Webcast
Prof. Deanfield and prof. Hobbs discuss the shift in focus from treating patients with clinical problems arising from established CV disease to CV prevention in patients with risk factors for developing CV disease.

Arrythmias:

Webcast
Which are important and what can you do? Dr. Frans Rutten, General Practitioner, Julius Center, Utrecht, The Netherlands

CVD in Europe:

Webcast
How do I assess risk and what's new? Prof. Terje R. Pedersen, MD, PhD, Professor of Medicine (Preventive Cardiology), University of Oslo, Norway

Diabetes

Webcast
What should glycaemic and blood pressure targets be? Dr. Neil Munro MMEd DPhil FR CGP Associate Specialist in Diabetes, Esher, United Kingdom

Transient Ischaemic Attacks:

Webcast
How to diagnose and what to do? Prof. Richard McManus Professor of Primary Care Cardiovascular Research and Honorary Consultant, Health and Population Sciences, University of Birmingham, United Kingdom

Co-morbidities in Heart Failure

Webcast
and improving concordance with treatments Professor. Arno Hoes Julius Center, Utrecht, The Netherlands

Should HDL and TGs be targeted in diabetes?

Webcast
Dr. Peter Lansberg, MD, PhD Academic Medical Centre, Amsterdam, The Netherlands

Summary EPCCS 2010 Hobbs

Webcast
Prof. Richard Hobbs gives an overview of highlights from EPCCS 2010 Click on picture to start video

Upcoming meetings

Meeting reports & resources

EPCCS Guidance Documents Evidence- and meeting-based guidance for primary care
EPCCS 2015 Report of 8th Annual EPCCS meeting held in Prague.
EPCCS 2014 Report of 7th Annual EPCCS meeting held in Brussels.
EPCCS 2013 Report of 6th Annual EPCCS meeting held in London
All meeting reports...